VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive: Studies have shown that KIAA1429 could promote the migration and invasion of cancer cells in breast cancer [5], lung adenocarcinoma [23,24], colorectal adenocarcinoma [11], gastric cancer [16], ovarian cancer [9], and chronic myeloid leukemia [25], indicating that KIAA1429 may be involved in the progress of multiple cancers.